• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

决定纳米载体靶向健康肺区与炎症肺区的机制。

Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.

作者信息

Brenner Jacob S, Bhamidipati Kartik, Glassman Patrick M, Ramakrishnan N, Jiang Depeng, Paris Andrew J, Myerson Jacob W, Pan Daniel C, Shuvaev Vladimir V, Villa Carlos H, Hood Elizabeth D, Kiseleva Raisa, Greineder Colin F, Radhakrishnan Ravi, Muzykantov Vladimir R

机构信息

Pulmonary and Critical Care Division, University of Pennsylvania, Philadelphia, PA, USA; Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Department of Pharmacology and Center for Translational Targeted Therapeutics and Nanomedicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nanomedicine. 2017 May;13(4):1495-1506. doi: 10.1016/j.nano.2016.12.019. Epub 2017 Jan 5.

DOI:10.1016/j.nano.2016.12.019
PMID:28065731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5518469/
Abstract

Inflamed organs display marked spatial heterogeneity of inflammation, with patches of inflamed tissue adjacent to healthy tissue. To investigate how nanocarriers (NCs) distribute between such patches, we created a mouse model that recapitulates the spatial heterogeneity of the inflammatory lung disease ARDS. NCs targeting the epitope PECAM strongly accumulated in the lungs, but were shunted away from inflamed lung regions due to hypoxic vasoconstriction (HVC). In contrast, ICAM-targeted NCs, which had lower whole-lung uptake than PECAM/NCs in inflamed lungs, displayed markedly higher NC levels in inflamed regions than PECAM/NCs, due to increased regional ICAM. Regional HVC, epitope expression, and capillary leak were sufficient to predict intra-organ of distribution of NCs, antibodies, and drugs. Importantly, these effects were not observable with traditional spatially-uniform models of ARDS, nor when examining only whole-organ uptake. This study underscores how examining NCs' intra-organ distribution in spatially heterogeneous animal models can guide rational NC design.

摘要

发炎的器官表现出明显的炎症空间异质性,发炎组织斑块与健康组织相邻。为了研究纳米载体(NCs)如何在这些斑块之间分布,我们创建了一个小鼠模型,该模型概括了炎症性肺病急性呼吸窘迫综合征(ARDS)的空间异质性。靶向表位PECAM的NCs在肺部大量积聚,但由于缺氧性血管收缩(HVC)而被分流至远离发炎肺区域。相比之下,靶向ICAM的NCs在发炎肺中的全肺摄取量低于PECAM/NCs,但由于区域ICAM增加,其在发炎区域的NC水平明显高于PECAM/NCs。区域HVC、表位表达和毛细血管渗漏足以预测NCs、抗体和药物在器官内的分布。重要的是,在传统的ARDS空间均匀模型中,以及仅检查全器官摄取时,这些效应均无法观察到。这项研究强调了在空间异质性动物模型中检查NCs在器官内的分布如何能够指导合理的NC设计。

相似文献

1
Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.决定纳米载体靶向健康肺区与炎症肺区的机制。
Nanomedicine. 2017 May;13(4):1495-1506. doi: 10.1016/j.nano.2016.12.019. Epub 2017 Jan 5.
2
Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.靶向不同PECAM-1表位的聚合物纳米载体在内皮细胞中的差异性递送。
J Control Release. 2008 Sep 24;130(3):226-33. doi: 10.1016/j.jconrel.2008.06.007. Epub 2008 Jun 18.
3
Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.受体靶向药物纳米载体与抗吞噬修饰物的共包被增强了特定组织摄取,而不是非特异性吞噬清除。
Biomaterials. 2017 Dec;147:14-25. doi: 10.1016/j.biomaterials.2017.08.045. Epub 2017 Sep 6.
4
Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.靶向多种内皮细胞粘附分子的联合策略可调节药物纳米载体及其治疗性载荷的结合、内吞作用和体内生物分布。
J Control Release. 2014 Aug 28;188:87-98. doi: 10.1016/j.jconrel.2014.06.008. Epub 2014 Jun 14.
5
Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.ICAM-1 靶向抗体与纳米载体在小鼠胃肠道中的体内分布与内吞作用。
Int J Nanomedicine. 2012;7:4223-37. doi: 10.2147/IJN.S34105. Epub 2012 Aug 1.
6
Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.通过调节血小板内皮细胞黏附分子-1/CD31表位结合协同增强纳米载体的内皮靶向性
ACS Nano. 2015 Jul 28;9(7):6785-93. doi: 10.1021/nn505672x. Epub 2015 Jul 13.
7
Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.流场对靶向 ICAM-1 的纳米载体内皮细胞内吞作用的影响。
J Control Release. 2012 Feb 10;157(3):485-92. doi: 10.1016/j.jconrel.2011.09.067. Epub 2011 Sep 16.
8
RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.RhoA激活和肌动蛋白重组参与内皮细胞黏附分子介导的抗PECAM载体的内吞作用:PECAM-1细胞质尾部酪氨酸686的关键作用。
Blood. 2008 Mar 15;111(6):3024-33. doi: 10.1182/blood-2007-06-098657. Epub 2008 Jan 8.
9
In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.聚合物纳米载体同时靶向同一或不同受体表位的体内性能。
Biomaterials. 2013 Apr;34(13):3459-66. doi: 10.1016/j.biomaterials.2013.01.069. Epub 2013 Feb 9.
10
Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates.多分子超氧化物歧化酶缀合物的大小以及靶向PECAM与ICAM对内皮细胞递送、内化和保护作用的影响。
J Control Release. 2016 Jul 28;234:115-23. doi: 10.1016/j.jconrel.2016.05.040. Epub 2016 May 20.

引用本文的文献

1
Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System.肺部边缘中性粒细胞有效地与靶向内皮的纳米颗粒竞争,作为网状内皮系统的一部分。
ACS Nano. 2024 Aug 20;18(33):22275-22297. doi: 10.1021/acsnano.4c06286. Epub 2024 Aug 6.
2
Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury.创伤性脑损伤后纳米颗粒对脑血管的靶向作用。
PLoS One. 2024 Jun 10;19(6):e0297451. doi: 10.1371/journal.pone.0297451. eCollection 2024.
3
Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting.脂质纳米颗粒的物理化学趋向性与亲和部分靶向相结合可增强器官靶向性。
Nano Lett. 2024 Apr 10. doi: 10.1021/acs.nanolett.3c05031.
4
Effect of acid sphingomyelinase deficiency in type A Niemann-Pick disease on the transport of therapeutic nanocarriers across the blood-brain barrier.溶酶体酸性鞘磷脂酶缺乏对 A 型尼曼-匹克病治疗性纳米载体透过血脑屏障转运的影响。
Drug Deliv Transl Res. 2023 Dec;13(12):3077-3093. doi: 10.1007/s13346-023-01374-z. Epub 2023 Jun 21.
5
A new mouse unilateral model of diffuse alveolar damage of the lung.一种新的单侧弥漫性肺泡损伤的小鼠模型。
Inflamm Res. 2022 Jun;71(5-6):627-639. doi: 10.1007/s00011-022-01568-0. Epub 2022 Apr 17.
6
Targeting vascular inflammation through emerging methods and drug carriers.通过新兴方法和药物载体靶向血管炎症。
Adv Drug Deliv Rev. 2022 May;184:114180. doi: 10.1016/j.addr.2022.114180. Epub 2022 Mar 7.
7
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers.双重亲和性红细胞和靶细胞(DART)增强了血管内纳米载体对器官和细胞类型的靶向性。
ACS Nano. 2022 Mar 22;16(3):4666-4683. doi: 10.1021/acsnano.1c11374. Epub 2022 Mar 10.
8
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).除了已有的炎症外,mRNA-脂质纳米颗粒还会引发炎症恶化(IE)。
J Control Release. 2022 Apr;344:50-61. doi: 10.1016/j.jconrel.2021.12.027. Epub 2021 Dec 23.
9
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.通过将补体调控蛋白与纳米颗粒偶联来对抗补体对纳米医学的有害影响。
Adv Mater. 2022 Feb;34(8):e2107070. doi: 10.1002/adma.202107070. Epub 2022 Jan 11.
10
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.红细胞:一个被忽视的载体向人工纳米载体天然母舰的蜕变。
Adv Drug Deliv Rev. 2021 Nov;178:113992. doi: 10.1016/j.addr.2021.113992. Epub 2021 Sep 29.

本文引用的文献

1
Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran.人内皮细胞中促炎基因的表达:利伐沙班与达比加群的比较
Thromb Res. 2016 Jun;142:44-51. doi: 10.1016/j.thromres.2016.04.008. Epub 2016 Apr 16.
2
Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.载有氟罗昔布A的纳米颗粒能够在炎症和癌症中实现环氧合酶-2的靶向可视化。
Biomaterials. 2016 Jun;92:71-80. doi: 10.1016/j.biomaterials.2016.03.028. Epub 2016 Mar 21.
3
Imaging in acute respiratory distress syndrome.急性呼吸窘迫综合征的影像学表现。
Intensive Care Med. 2016 May;42(5):686-698. doi: 10.1007/s00134-016-4328-1. Epub 2016 Mar 31.
4
β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.β1-Na(+),K(+)-ATP酶基因疗法上调紧密连接以挽救脂多糖诱导的急性肺损伤。
Gene Ther. 2016 Jun;23(6):489-99. doi: 10.1038/gt.2016.19. Epub 2016 Mar 17.
5
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
6
Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction.用于心肌梗死后心脏组织靶向聚集和长期保留的酶响应性纳米颗粒。
Adv Mater. 2015 Oct 7;27(37):5547-52. doi: 10.1002/adma.201502003. Epub 2015 Aug 25.
7
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery.通过与Sn2脂肪酶不稳定前药进行接触促进给药,优化靶向脂质纳米颗粒药物递送。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jan-Feb;8(1):85-106. doi: 10.1002/wnan.1355. Epub 2015 Aug 21.
8
Spatial and temporal cancer evolution: causes and consequences of tumour diversity.癌症的时空演变:肿瘤异质性的成因与后果
Clin Med (Lond). 2014 Dec;14 Suppl 6:s33-7. doi: 10.7861/clinmedicine.14-6-s33.
9
SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.圣脂质体-聚阳离子颗粒,一种用于改善小干扰RNA向炎症内皮细胞递送的新型载体。
Eur J Pharm Biopharm. 2015 Jan;89:40-7. doi: 10.1016/j.ejpb.2014.11.015. Epub 2014 Nov 25.
10
Impact of emphysema heterogeneity on pulmonary function.肺气肿异质性对肺功能的影响。
PLoS One. 2014 Nov 19;9(11):e113320. doi: 10.1371/journal.pone.0113320. eCollection 2014.